national stem-cell therapy logo

Revolutionary Breakthrough: New Drug Prototype Regenerates Lung Tissue

image of lung regeneration with stem cells

In an extraordinary leap forward for medical science, a group of scientists at Scripps Research and its drug discovery arm, the Calibr-Skaggs Institute for Innovative Medicines, have developed a new drug prototype that has the potential to regenerate damaged lung tissue. This innovative treatment could be a game-changer for patients suffering from respiratory diseases. The […]

Revolutionizing ALS Treatment: BrainStorm’s Phase 3b Trial Moves Forward with FDA Approval

BrainStorm Logo

BrainStorm Cell Therapeutics Inc., a leader in adult stem cell therapeutics for neurodegenerative diseases, has achieved a significant milestone with the FDA’s agreement on a Special Protocol Assessment (SPA) for its Phase 3b trial of NurOwn® in amyotrophic lateral sclerosis (ALS). This agreement marks a critical step in advancing the potential treatment to the market, […]

Unlocking the Secrets of the Universe to Combat Neurodegenerative Diseases: NASA’s SpaceX CRS-30 Mission

NASA's SpaceX mission to Combat Neurodegenerative Diseases

In an unprecedented move towards understanding and potentially halting the progression of neurodegenerative diseases, NASA’s SpaceX CRS-30 Mission, in collaboration with the National Stem Cell Foundation, is set to launch its 6th investigation into the mysteries of these conditions. This mission marks a significant step forward in the fight against debilitating diseases like Alzheimer’s, Parkinson’s […]

Celularity Revolutionizing Cancer Treatment: The Breakthrough of Stem Cell Therapy

celularity-logo

A New Era in Oncology In an exciting development for the field of oncology, Celularity Inc., a leading biotechnology company, is set to present compelling in vivo data at the AACR Annual Meeting 2024. This data showcases the significant impact of their groundbreaking stem cell therapy, PT-CD16, in reducing cancer tumors. Derived from human placental […]

BioCardia Unveils Groundbreaking Results in Phase III CardiAMP Cell Therapy for Heart Failure

BioCardia Logo

BioCardia, Inc., a leader in biotechnological advancements for cardiovascular diseases, recently announced remarkable interim results from its Phase III CardiAMP® Cell Therapy trial for treating advanced chronic heart failure. These findings mark a significant milestone in the pursuit of innovative treatments for heart failure, showcasing the potential of stem cell therapy to revolutionize patient care. […]

Unlocking the Potential of Exosomes in Brain Health: A Leap Forward by Kimera Labs

Kimera Exosome logo

In the ever-evolving field of regenerative medicine, Mesenchymal Stem Cells (MSCs) and their secreted exosomes represent a frontier of hope for conditions once deemed untreatable. Kimera Labs, a pioneer in MSC exosome research and production, has recently made headlines with its groundbreaking work on brain targeting of exosomes, as highlighted in Nature Scientific Reports. This […]

The Dawn of a New Era in Heart Failure Treatment: BioCardia’s CardiAMP Heart Failure II Phase 3 Pivotal Study

BioCardia Logo

In an exciting development for the field of cardiovascular medicine, BioCardia, Inc., a pioneering biotechnology company, has announced the activation of the CardiAMP Heart Failure II Phase 3 pivotal study. This groundbreaking study, recently greenlit by the FDA, represents a significant leap forward in the treatment of ischemic heart failure through advanced cell therapy techniques. […]

Coeptis Therapeutics Advances with Groundbreaking Stem Cell Therapy in Phase 2 Program

Coeptis Therapeutics

In a significant stride towards revolutionizing the treatment of viral infections, Coeptis Therapeutics, Inc., a name synonymous with innovation in the biopharmaceutical realm, has announced its plans to embark on a Phase 2 program. This program is centered around its proprietary, first-in-class allogeneic NK cell therapy, showcasing a pivotal moment in the pursuit of advanced […]

Pioneering Neurodegenerative Disease Research with Stem Cell-Derived Brain Organoids in Space

ISS National Laboratory logo

The Groundbreaking Mission: In a significant leap towards understanding neurodegenerative disorders, the International Space Station National Lab is hosting an innovative research project. This project involves stem cell-derived brain organoids being sent to space as part of Axiom Space’s third private astronaut mission. The objective is to improve the modeling of diseases like Parkinson’s disease […]

CRISPR Therapeutics’ FDA Approval for CASGEVY™

FDA Approved sign

CRISPR Therapeutics has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) approving CASGEVY™ (exagamglogene autotemcel [exa-cel]), a groundbreaking CRISPR/Cas9 gene-edited cell therapy. This approval makes CASGEVY available for the treatment of transfusion-dependent beta thalassemia (TDT) in patients aged 12 and older. Approximately 1,000 patients in the U.S. are now eligible for […]